A @bloodadvances.bsky.socials study shows reduced-intensity conditioning haplo-BMT with posttransplant cyclophosphamide achieved a 96% overall survival rate in young severe aplastic anemia patients, offering a safe and effective cure. 🩸
Read more: https://bit.ly/4i4Li9b
#PedHem
Read more: https://bit.ly/4i4Li9b
#PedHem
October 9, 2026 at 1:20 PM
A @bloodadvances.bsky.socials study shows reduced-intensity conditioning haplo-BMT with posttransplant cyclophosphamide achieved a 96% overall survival rate in young severe aplastic anemia patients, offering a safe and effective cure. 🩸
Read more: https://bit.ly/4i4Li9b
#PedHem
Read more: https://bit.ly/4i4Li9b
#PedHem
ICYMI❗ From The 2026 ASPHO Conference
Declining rates of Rh-associated HDF means lack of clinical exposure leading to delayed diagnoses and subsequent undertreatment.
E-learning curriculum has shown to improve #HDFN outcomes 🧬📈
Read more: https://bit.ly/4wsHq75
#ASPHO2026 #PedHem
Declining rates of Rh-associated HDF means lack of clinical exposure leading to delayed diagnoses and subsequent undertreatment.
E-learning curriculum has shown to improve #HDFN outcomes 🧬📈
Read more: https://bit.ly/4wsHq75
#ASPHO2026 #PedHem
E-Learning Curriculum Can Improve Clinical Decision-Making in Rh-Linked HDFN
The global prevalence of Rh-associated HDFN is estimated at 256 per 100,000 live births, whereas the prevalence in high-income nations is approximately 2.5 per 100,000 live births—the latter statistic...
bit.ly
May 14, 2026 at 7:11 PM
ICYMI❗ From The 2026 ASPHO Conference
Declining rates of Rh-associated HDF means lack of clinical exposure leading to delayed diagnoses and subsequent undertreatment.
E-learning curriculum has shown to improve #HDFN outcomes 🧬📈
Read more: https://bit.ly/4wsHq75
#ASPHO2026 #PedHem
Declining rates of Rh-associated HDF means lack of clinical exposure leading to delayed diagnoses and subsequent undertreatment.
E-learning curriculum has shown to improve #HDFN outcomes 🧬📈
Read more: https://bit.ly/4wsHq75
#ASPHO2026 #PedHem
More from the 2026 @ASPHO_hq Conference!
ITI Alone Leads to Shorter Time to Inhibitor Clearance in Pediatric Hemophilia A: https://bit.ly/4emlFPV
#HemOnc #PedOnc #PedHem
ITI Alone Leads to Shorter Time to Inhibitor Clearance in Pediatric Hemophilia A: https://bit.ly/4emlFPV
#HemOnc #PedOnc #PedHem
May 5, 2026 at 5:56 PM
More from the 2026 @ASPHO_hq Conference!
ITI Alone Leads to Shorter Time to Inhibitor Clearance in Pediatric Hemophilia A: https://bit.ly/4emlFPV
#HemOnc #PedOnc #PedHem
ITI Alone Leads to Shorter Time to Inhibitor Clearance in Pediatric Hemophilia A: https://bit.ly/4emlFPV
#HemOnc #PedOnc #PedHem